Literature DB >> 2543885

In vivo and in vitro models of demyelinating diseases. XXIV. The infectious process in cyclosporin A treated Wistar Lewis rats inoculated with JHM virus.

M J Zimmer1, S Dales.   

Abstract

In the present study we investigated age related effects of inoculum size and cellular immunity on the CNS disease caused by JHM virus (JHMV) in Wistar Lewis (WL) rats. Onset of resistance normally becomes evident by the 10th day when inoculation is made with 10(5) pfu or less. The resistance could be abrogated in 15 day old animals by increasing the dose two-fold, but with rare exceptions, in 35 day old rats an 80-fold increase in pfu fails to surmount resistance. However, treatment with the immunosuppressant drug cyclosporin A (CsA) abolished resistance, whereby rats challenged at 35 days of age were susceptible to JHMV. The histopathological evidence and disease symptoms in the CsA treated group resembled closely those observed in our previous study with athymic, nude rats. Microscopic examination of the CNS from untreated, infected rats revealed extensive inflammatory responses characterized by perivascular cuffing and mononuclear infiltrates into the neuropile. The parallel CsA treated group showed that inflammatory responses of this type in the CNS were either minimal or absent. From the present evidence, we conclude that JHMV infection, which involves both neuronal and oligodendrocytic elements, is kept in check by the cellular immune system. When cellular immunity is suppressed or absent the disease process is altered from one in which white matter demyelination predominates to another form of disease in which neuronal involvement is prominent.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2543885      PMCID: PMC7135175          DOI: 10.1016/0882-4010(89)90003-x

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  18 in total

1.  In vivo and in vitro models of demyelinating disease, XXI: relationship between differentiation of rat oligodendrocytes and control of JHMV replication.

Authors:  S Beushausen; S Dales
Journal:  Adv Exp Med Biol       Date:  1987       Impact factor: 2.622

2.  Corona virus induced subacute demyelinating encephalomyelitis in rats: a morphological analysis.

Authors:  K Nagashima; H Wege; R Meyermann; V ter Meulen
Journal:  Acta Neuropathol       Date:  1978-10-13       Impact factor: 17.088

3.  Comparative analysis of coronavirus JHM-induced demyelinating encephalomyelitis in Lewis and Brown Norway rats.

Authors:  R Watanabe; H Wege; V ter Meulen
Journal:  Lab Invest       Date:  1987-10       Impact factor: 5.662

4.  Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate.

Authors:  G Sobue; D Pleasure
Journal:  Science       Date:  1984-04-06       Impact factor: 47.728

5.  Allergic encephalomyelitis in the reputedly resistant Brown Norway strain of rats.

Authors:  S Levine; R Sowinski
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

6.  In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice.

Authors:  O Sorensen; R Dugre; D Percy; S Dales
Journal:  Infect Immun       Date:  1982-09       Impact factor: 3.441

7.  In vivo and in vitro models of demyelinating diseases. III. JHM virus infection of rats.

Authors:  O Sorensen; D Perry; S Dales
Journal:  Arch Neurol       Date:  1980-08

8.  Immunosuppression by cyclosporin A of experimental allergic encephalomyelitis.

Authors:  C Bolton; J F Borel; M L Cuzner; A N Davison; A M Turner
Journal:  J Neurol Sci       Date:  1982-11       Impact factor: 3.181

9.  Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.

Authors:  C Feurer; D E Prentice; S Cammisuli
Journal:  J Neuroimmunol       Date:  1985-12       Impact factor: 3.478

10.  In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy.

Authors:  O Sorensen; S Dales
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more
  7 in total

1.  Infection by coronavirus JHM of rat neurons and oligodendrocyte-type-2 astrocyte lineage cells during distinct developmental stages.

Authors:  J M Pasick; S Dales
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 2.  The murine coronavirus as a model of trafficking and assembly of viral proteins in neural tissue.

Authors:  K Kalicharran; S Dales
Journal:  Trends Microbiol       Date:  1996-07       Impact factor: 17.079

3.  Identification of the spinal cord as a major site of persistence during chronic infection with a murine coronavirus.

Authors:  S Perlman; G Jacobsen; A L Olson; A Afifi
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

4.  Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated.

Authors:  F I Wang; S A Stohlman; J O Fleming
Journal:  J Neuroimmunol       Date:  1990-11       Impact factor: 3.478

5.  Vacuolating encephalitis in mice infected by human coronavirus OC43.

Authors:  Hélène Jacomy; Pierre J Talbot
Journal:  Virology       Date:  2003-10-10       Impact factor: 3.616

6.  Immune response to a murine coronavirus: identification of a homing receptor-negative CD4+ T cell subset that responds to viral glycoproteins.

Authors:  J Mobley; G Evans; M O Dailey; S Perlman
Journal:  Virology       Date:  1992-04       Impact factor: 3.616

7.  Beta-endorphin protects mice from neurological disease induced by the murine coronavirus MHV-JHM.

Authors:  W Gilmore; D S Moradzadeh
Journal:  J Neuroimmunol       Date:  1993-10       Impact factor: 3.478

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.